Novartis (NVS) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
Barclays Downgrades Novartis (NVS) to Underweight
October 25, 2017 1:39 AM EDTBarclays downgraded Novartis (NYSE: NVS) from Equalweight to Underweight.
Analyst Emmanuel Papadakis believes the underlying business is running well but suspects Street expectations for Entresto are too high while competitive risks are increasing with Cosentyx. The analyst sees limited catalysts beyond... More



